Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1993-10-12
pubmed:abstractText
In order to clarify antigenic variations among various isolates of human herpesvirus 6 (HHV-6) and cross-reactivity among HHV-6, HHV-7, and human cytomegalovirus (HCMV) in the T-cell immune response, the antigenic specificity of the proliferative response mediated by 232 CD4+ human T-cell clones directed against HHV-6, HHV-7, or HCMV was examined. The results obtained were as follows. (i) Although the majority of T-cell clones directed against HHV-6 proliferated in response to stimulation with all strains of HHV-6 used (U1102, Z29, SF, and HST), 7% (8 of 122) of the T-cell clones showed distinct patterns of proliferative response against strain U1102 (group A) and other strains of HHV-6 (group B). (ii) Of 99 T-cell clones, 71 showed a distinct proliferative response to HHV-6 and HHV-7, whereas 28 proliferated in response to stimulation with both HHV-6 and HHV-7. (iii) A small number of T-cell clones (9 of 232) showed cross-reactivity against HHV-6 and HCMV, and 2 of the 232 clones were reactive with HCMV as well as with HHV-6 and HHV-7. (iv) The specificity of gamma interferon production by T-cell clones following the stimulation with virus antigen was identical to that of their proliferative response. These data thus indicate the presence of antigenic variations among isolates of HHV-6 and also epitopes common to HHV-6 and HHV-7 and to HHV-6, HHV-7, and HCMV which are recognized by CD4+ T cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1321206, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1328500, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1329336, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1332051, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1348547, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1348548, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1648234, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1653487, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1656093, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1661364, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1677066, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1848868, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-1975142, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2152817, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2161178, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2169499, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2476493, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2547886, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2574396, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2876520, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2886840, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-2896909, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-3259614, http://linkedlifedata.com/resource/pubmed/commentcorrection/8396680-8381815
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6259-64
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus.
pubmed:affiliation
First Department of Internal Medicine, Ehime University School of Medicine, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't